LM-101
- Generic Name
- LM-101
A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- LaNova Medicines Limited
- Target Recruit Count
- 139
- Registration Number
- NCT05615974
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
🇨🇳Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
🇨🇳Linyi Cancer Hospital, Linyi, Shandong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath